WATSON 460 (Glipizide 5 mg)
Pill imprint WATSON 460 has been identified as Glipizide 5 mg.
Glipizide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glipizide 5 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for WATSON 460 (Glipizide 5 mg)
- 5 mg
- 8.00 mm
- Prescription only
- Drug Class:
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Watson Laboratories, Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
|NDC Code||Manufacturer / Repackager|
|63739-0116||McKesson Packaging Services|
|54569-3841||A S Medication Solutions LLC (repackager)|
|49999-0108||Lake Erie Medical and Surgical Supply (repackager)|
|63874-0316||Altura Pharmaceuticals Inc (repackager)|
|58016-0876||Southwood Pharmaceuticals Inc (repackager)|
|55289-0806||PDRX Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.
More about glipizide
Compare with other treatments for:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...